Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non–Small Cell Lung Cancer
Mohammadhadi Khorrami(Case Western Reserve University), Anant Madabhushi(Emory University), Pradnya D. Patil(Cleveland Clinic), Prateek Prasanna(Case Western Reserve University), Germán Corredor(Emory University), Amit Gupta(University of Washington), Priya Velu(University of Pennsylvania), Pingfu Fu(Medical College of Wisconsin), Vamsidhar Velcheti(Cleveland Clinic), Kaustav Bera(University Hospitals of Cleveland), Rajat Thawani(Maimonides Medical Center), Mehdi Alilou(Case Western Reserve University), Michael D. Feldman(University of Pennsylvania)
Cited by 313
Related Papers
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|835
Predicting cancer outcomes with radiomics and artificial intelligence in radiology
|Nature Reviews Clinical Oncology|2021|810
Programmed death ligand-1 expression in non-small cell lung cancer
|Laboratory Investigation|2013|753
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|416